SCHEMBL13059348

SCHEMBL13059348

CCC(C(=O)NCC(C)C)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 2/20 0.59
CTSK P43235 2/20 0.59
POLB P06746 1/20 0.54
CRHBP P24387 2/20 0.52
CRHR2 Q13324 2/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
KCNQ2 O43526 2/20 0.51
KDM4A O75164 1/20 0.51
MAPT P10636 1/20 0.51
GAA P10253 1/20 0.50
ALDH1A1 P00352 1/20 0.47
PTGS2 P35354 1/20 0.46
BACE1 P56817 1/20 0.46
BACE2 Q9Y5Z0 1/20 0.46
CTSL P07711 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.46
NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13059171 0.83 PTGS2 (0.59) CTSSCTSKMEN1KMT2AMAPT
Xenbucin SCHEMBL24134 0.77 PTGS2 (0.58) CTSSCTSKCRHBPCRHR2KCNQ2
SCHEMBL4558922 0.76 PTGS2 (0.52) CTSSCTSKPOLBCRHBPCRHR2
SCHEMBL27932526 0.76 POLB (0.69) POLBCRHBPCRHR2MEN1KMT2A
Xenbucin SCHEMBL3360074 0.74 PTGS2 (0.55) CTSSCTSKCRHBPCRHR2KCNQ2
SCHEMBL27620277 0.74 PTGS2 (0.50) CTSSCTSKPOLBCRHBPCRHR2
SCHEMBL4714562 0.74 CTSK (1.00) CTSSCTSKCTSL
SCHEMBL4718865 0.73 CTSK (0.78) CTSSCTSKCTSL
Xenbucin SCHEMBL29388884 0.73 PTGS2 (0.49) CTSSCTSKPOLBCRHBPCRHR2
SCHEMBL402514 0.73 POLB (0.65) POLBCRHBPCRHR2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240065302-A1 SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF FIRMENICH INCORPORATED 2024-02-29 US disclosed
US-20180086751-A1 SWEETENER COMPOSITION SENOMYX, INC. 2018-03-29 US disclosed
US-7842324-B2 Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers SENOMYX, INC. (US) 2010-11-30 US disclosed
US-7842324-B2 Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers SENOMYX, INC. (US) 2010-11-30 US disclosed
US-20070003680-A1 Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers SENOMYX, INC. 2007-01-04 US disclosed
US-20070003680-A1 Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers SENOMYX, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086751-A1 SWEETENER COMPOSITION TAS2R50, TAS1R2, TAS2R10 CTSS 2269/4885CTSK 1558/4885POLB 3532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.